000			02940cam a2200385 i 4500
001			11272
003			MEMOS
005			20240731094755.0
008			191002s2020 enka b 001 0 eng
010			_a 2019951897
020			_a9780128186077 _q(paperback)
020			_z9780128197882 _q(ebook)
040			_aMEMOS _beng _erda _cDLC _dMEMOS
042			_apcc
050	0	0	_aQH438.4.B55 _bP76 2020
082			_223 _a572.6 _bP967
245	0	0	_aProteomic and metabolomic approaches to biomarker discovery / _cedited by Haleem J. Issaq, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States, Timothy D. Veenstra, Department of Applied Sciences, Maranatha Baptist University, Watertown, WI, United States.
250			_aSecond edition.
260			_aUnited Kingdom : _bAcademic Press, _c[2020]
264		1	_a _b _c
300			_axvi, 487 pages : _billustrations (chiefly color) ; _c24 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
500			_aRevised edition of: Proteomic and metabolomic approaches to biomarker discovery / Haleem J. Issaq, Timothy D. Veenstra. [2013].
504			_aIncludes bibliographical references and index.
520			_a"Proteomic and Metabolomic Approaches to Biomarker Discovery, Second Edition covers techniques from both proteomics and metabolomics and includes all steps involved in biomarker discovery, from study design to study execution. The book describes methods and presents a standard operating procedure for sample selection, preparation and storage, as well as data analysis and modeling. This new standard effectively eliminates the differing methodologies used in studies and creates a unified approach. Readers will learn the advantages and disadvantages of the various techniques discussed, as well as potential difficulties inherent to all steps in the biomarker discovery process. This second edition has been fully updated and revised to address recent advances in MS and NMR instrumentation, high-field NMR, proteomics and metabolomics for biomarker validation, clinical assays of biomarkers and clinical MS and NMR, identifying microRNAs and autoantibodies as biomarkers, MRM-MS assay development, top-down MS, glycosylation-based serum biomarkers, cell surface proteins in biomarker discovery, lipodomics for cancer biomarker discovery, and strategies to design studies to identify predictive biomarkers in cancer research"-- _cProvided by publisher.
650		0	_aBiochemical markers.
650		0	_aProteomics.
700	1		_aIssaq, Haleem J., _eeditor.
700	1		_aVeenstra, Timothy Daniel, _d1966- _eeditor.
906			_a2022-6000 _b _c _d _e _f _g
942			_2ddc _cBK _n0
999			_c13701 _d13701